Long-term benefit from anti-hormonal treatment is influenced by menopausal status: Study
"Younger women generally have a higher risk of recurrence than older postmenopausal women, but most studies on anti-hormonal therapy have mainly included postmenopausal women. We therefore wanted to compare the long-term benefit from the treatment in both groups," says Linda Lindstrom, associate professor and research group leader at the Department of Oncology-Pathology, Karolinska Institutet, who led the study.
